Amrix
NDC Package 21695-723-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Amrix is cyclobenzaprine is used short-term to treat muscle spasms. Marketed by Rebel Distributors Corp., this product is identified by NDC 21695-723 and is authorized under FDA application NDA021777.

Identification & Billing

NDC Package Code
21695-723-28
Package Description
28 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
21695-723
11-Digit Billing Format
21695072328
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
28 EA
RxNorm Crosswalk
  • RxCUI: 828358 - cyclobenzaprine HCl 15 MG 24HR Extended Release Oral Capsule
  • RxCUI: 828358 - 24 HR cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule
  • RxCUI: 828358 - cyclobenzaprine hydrochloride 15 MG 24 HR Extended Release Oral Capsule
  • RxCUI: 828359 - Amrix 15 MG 24HR Extended Release Oral Capsule
  • RxCUI: 828359 - 24 HR cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule [Amrix]

Clinical Specifications

Proprietary Name
Amrix
Dosage Form
-
Usage Information
Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Regulatory & Marketing

Labeler Name
Rebel Distributors Corp.
FDA Application #
NDA021777
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2007
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (21695-723). Click a package code to view its specific billing and regulatory data.

21695-723-14
14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
21695-723-60
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21695-723-28 identifies a specific commercial package of 28 capsule, extended release in 1 bottle of Amrix, labeled by Rebel Distributors Corp.. This product is billed for "EA" each discreet unit and contains an estimated amount of 28 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp. on October 01, 2007. The current certification is valid through December 31, 2017.

What are the primary indications for this medication?

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

How is this Rebel Distributors Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695072328. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 28 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21695-723-28
11-Digit CMS (5-4-2)
21695-0723-28

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.